Opendata, web and dolomites

CG-100

A next generation medical device that enhances patient care and treatment following colorectal surgery

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 CG-100 project word cloud

Explore the words cloud of the CG-100 project. It provides you a very rough idea of what is the project "CG-100" about.

diseases    improves    employ    2014    colonic    received    depression    clinical    confidently    mark    medical    anastomosis    cancer    pains    waste    content    marketing    stage    quality    doctors    company    headquartered    entrepreneurs    skin    companies    device    subcontractors    leakage    parastomal    site    trials    contact    profound    ce    single    surgery    ulcers    economic    al    hernia    complication    threatening    advisors    ostomy    causing    chronic    date    complications    surgeons    procedure    2010    moving    infections    functions    shown    multiple    eur    risky    vast    employees    internal    faecal    leads    patients    intraluminal    cologuard    life    founded    diverting    stoma    proprietary    time    colorectal    prevent    dec    sepsis    healthcare    silicon    solution    team    50    anastomotic    stomas    reducing    bags    ltd    external    patient    care    comprising    bag    place    healing    cg    bypass    active    full    israel    leaks    talks   

Project "CG-100" data sheet

The following table provides information about the project.

Coordinator
COLOSPAN LTD 

Organization address
address: 21 ATIR YEDA STREET
city: KFAR SABA
postcode: 4464316
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Israel [IL]
 Project website http://www.cologuard.co.il
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3.1.3. (Treating and managing disease)
 Code Call H2020-SMEINST-1-2016-2017
 Funding Scheme SME-1
 Starting year 2017
 Duration (year-month-day) from 2017-03-01   to  2017-06-30

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    COLOSPAN LTD IL (KFAR SABA) coordinator 50˙000.00

Map

 Project objective

Cologuard Ltd is a clinical stage medical device company founded in Dec 2010. Cologuard's novel and proprietary technology for colorectal surgery was developed in order to prevent the profound clinical and economic pains associated with anastomotic leaks and diverting colonic stomas. Anastomotic leakage (AL) is a life threatening complication, which can occur following colorectal surgery for colorectal cancer or other diseases. In order to prevent AL, surgeons use a procedure called diverting stoma, which result in an ostomy bag for external bypass of waste. This solution leads to a low quality of life for patients, causing many clinical complications, including sepsis, parastomal hernia, ulcers, chronic depression and skin infections. In addition, this procedure has a high economic cost for the patient and the healthcare system. The Cologuard team have developed the CG-100, a single use intraluminal device composed of silicon, which functions as an internal bypass for colonic content, reducing contact between faecal content and the anastomosis site. The device allows healing to take place without the need for an external diverting stoma and ostomy bag. The CG-100 device improves patient care through the reduction of risky complications associated with ostomy bags, improving the healing process and providing a better quality of life. Healthcare costs will be greatly reduced by up to 50%. The company is composed of a strong team comprising top doctors and medical advisors as well as entrepreneurs with vast experience in the medical device sector. The company received CE mark for its lead product in 2014 and is confidently moving towards pre-marketing clinical trials in the EU. Cologuard has received over 4.2 M EUR funding to date. The company is headquartered in Israel and employ 5 full time employees and multiple subcontractors. The company is currently in talks with companies in the EU who have shown an active interest in the project.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "CG-100" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "CG-100" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.1.3.)

ENDOSCAPE (2019)

ENDOSCAPE, a clinically applicable non-viral gene delivery technology

Read More  

LEGACy (2019)

CeLac and European consortium for a personalized medicine approach to Gastric Cancer

Read More  

PREFERABLE (2019)

Project on Exercise for Fatigue Eradication in Advanced Breast cancer to improve quality of life

Read More